Coeur Mining's Pullback Masks Persistent Valuation and Execution Risks

What happened

Coeur Mining reported record Q4 and full-year 2025 results, with revenue nearly doubling to $2.07 billion and net income surging to $585.9 million, driven by operational improvements. A Seeking Alpha article published on March 16, 2026, rates CDE a buy after a 25% pullback, highlighting the New Gold integration as a catalyst for projected $3 billion EBITDA and $2 billion free cash flow in 2026. However, DeepValue's master report indicates that at $19.11, the stock already prices in a high-expectations execution stack, including successful Rochester expansion, Las Chispas cost normalization, and a timely New Gold closure in H1 2026. The report warns of no margin of safety, with valuation at 38.0x EV/EBITDA and 29.7x P/E, and flags execution fragility at Rochester, integration noise from purchase price accounting at Las Chispas, and pending Investment Canada Act approval. Despite the bullish narrative, critical uncertainties around deal timing and operational delivery create a crowded, momentum-driven environment with limited downside protection.

Implication

The near-term optimism from record financials is tempered by DeepValue's analysis showing valuation already embeds perfect execution, making current prices unattractive without hard catalysts. Upcoming milestones, including FY2025 results on February 18, 2026, which will frame 2026 guidance, and the Investment Canada Act approval for the New Gold deal, are critical to validate the $3 billion EBITDA narrative. Operational risks, such as Rochester's throughput and recovery misses flagged in filings, could impair cash flow and erode the expansion economics underpinning the stock's rerating. Insider selling in mid-2025, though not conclusive, adds to caution by suggesting internal perspectives may align with the high-expectation, crowded trade setup. Ultimately, patience for a lower entry or clearer de-risking improves expected returns, as the current setup offers little cushion for delays or cost overruns.

Thesis delta

The new article's bullish call does not shift the fundamental thesis; DeepValue's WAIT rating remains appropriate due to persistently high valuation and unresolved execution risks. Any upgrade would require concrete progress, such as Investment Canada Act approval by mid-2026 or guidance that sustains production targets without slippage, which are not yet evident.